US Stock MarketDetailed Quotes

OTLK Outlook Therapeutics

Watchlist
  • 7.550
  • -0.180-2.33%
Trading May 10 15:48 ET
175.90MMarket Cap-1887P/E (TTM)

About Outlook Therapeutics Company

Outlook Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of ONS-5010/LYTENAVA. Its pipeline includes unmet patient needs, repackaged IV bevacizumab, and anti-VEGF. The company was founded by Pankaj Mohan on January 5, 2010 and is headquartered in Iselin, NJ.

Company Profile

SymbolOTLK
Company NameOutlook Therapeutics
Listing DateJun 13, 2016
Founded2010
CEOMr. C. Russell Trenary, III
MarketNASDAQ
Employees24
Securities TypeOrdinary Shares
Fiscal Year Ends09-30
Address111 South Wood Avenue,Unit 100
CityIselin
ProvinceNew Jersey
CountryUnited States of America
Zip Code08830
Phone1-609-619-3990
Websitehttp://www.outlooktherapeutics.com

Company Executives

  • Name
  • Position
  • Salary
  • C. Russell Trenary, III
  • President, Chief Executive Officer and Director
  • 1.76M
  • Lawrence A. Kenyon
  • Chief Financial Officer, Executive Vice President, Treasurer, Secretary, Principal Accounting Officer and Director
  • 1.86M
  • Jeff Evanson
  • Chief Commercial Officer
  • 718.20K
  • Ralph H. Thurman
  • Executive Chairman of the Board
  • 242.50K
  • Andong Huang
  • Independent Director
  • 75.00K
  • Julian S. Gangolli
  • Independent Director
  • 112.50K
  • Dr. Julia A. Haller, M.D.
  • Independent Director
  • 79.00K
  • Yezan Munther Haddadin
  • Independent Director
  • 110.00K
  • Faisal G. Sukhtian
  • Independent Director
  • 113.00K
  • Dr. Gerd U. Auffarth, M.D.
  • Independent Director
  • 79.00K
  • Kurt J. Hilzinger
  • Independent Director
  • 95.00K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg